1. Home
  2. ACHV vs CHEB Comparison

ACHV vs CHEB Comparison

Compare ACHV & CHEB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHV
  • CHEB
  • Stock Information
  • Founded
  • ACHV N/A
  • CHEB 2024
  • Country
  • ACHV United States
  • CHEB Singapore
  • Employees
  • ACHV N/A
  • CHEB N/A
  • Industry
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • CHEB
  • Sector
  • ACHV Health Care
  • CHEB
  • Exchange
  • ACHV Nasdaq
  • CHEB NYSE
  • Market Cap
  • ACHV 131.2M
  • CHEB 122.8M
  • IPO Year
  • ACHV N/A
  • CHEB 2024
  • Fundamental
  • Price
  • ACHV $2.68
  • CHEB $9.44
  • Analyst Decision
  • ACHV Strong Buy
  • CHEB
  • Analyst Count
  • ACHV 3
  • CHEB 0
  • Target Price
  • ACHV $14.33
  • CHEB N/A
  • AVG Volume (30 Days)
  • ACHV 2.0M
  • CHEB 22.5K
  • Earning Date
  • ACHV 08-07-2025
  • CHEB 01-01-0001
  • Dividend Yield
  • ACHV N/A
  • CHEB N/A
  • EPS Growth
  • ACHV N/A
  • CHEB N/A
  • EPS
  • ACHV N/A
  • CHEB N/A
  • Revenue
  • ACHV N/A
  • CHEB N/A
  • Revenue This Year
  • ACHV N/A
  • CHEB N/A
  • Revenue Next Year
  • ACHV N/A
  • CHEB N/A
  • P/E Ratio
  • ACHV N/A
  • CHEB N/A
  • Revenue Growth
  • ACHV N/A
  • CHEB N/A
  • 52 Week Low
  • ACHV $1.84
  • CHEB $6.09
  • 52 Week High
  • ACHV $5.31
  • CHEB $14.31
  • Technical
  • Relative Strength Index (RSI)
  • ACHV 48.14
  • CHEB N/A
  • Support Level
  • ACHV $2.58
  • CHEB N/A
  • Resistance Level
  • ACHV $2.77
  • CHEB N/A
  • Average True Range (ATR)
  • ACHV 0.18
  • CHEB 0.00
  • MACD
  • ACHV 0.05
  • CHEB 0.00
  • Stochastic Oscillator
  • ACHV 78.48
  • CHEB 0.00

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

About CHEB CHENGHE ACQUISITION II CO

Chenghe Acquisition II Co is a blank check company.

Share on Social Networks: